Nicotine Pouches, Youth Use, Harm Reduction, and Marketing: Scoping Review with ☸️SAIMSARA.

Name: SAIMSARA Evidence Object longevity::NICOTINE_POUCHES_PM
Creator: SAIMSARA
License: https://saimsara.com/license/

SAIMSARA

doi:10.62487/saimsaradf0814e3

SAIMSARA Journal

Machine-Readable Science • ISSN 3054-3991

Nicotine Pouches, Youth Use, Harm Reduction, and Marketing: Scoping Review with ☸️SAIMSARA.

Longevity & Public Health

Issue 2, Volume 1, 2026

Chat with this issue

DOI: 10.62487/saimsaradf0814e3

Editorial note

• Last update: 2026-05-28 19:46:27

What is this paper about

Nicotine pouches sit at the centre of a public-health paradox: they may reduce toxicant exposure for adult smokers who fully switch, yet the evidence map shows rapid youth uptake driven by flavors, TikTok visibility, product appeal, and aggressive marketing. The full review separates harm-reduction promise from initiation risk, mapping 109 references across pharmacokinetics, oral safety, biomarkers, youth use, regulation, and the fast-moving nicotine-analogue market.

Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.

Video summary generated from this ☸️SAIMSARA evidence map. Full reference-linked paper and evidence JSON are available after purchase.

Abstract: This scoping review systematically maps the breadth of original scientific evidence on nicotine pouches, spanning prevalence and patterns of use, product chemistry and pharmacokinetics, toxicological and clinical safety, marketing and media representation, and regulatory considerations, in order to identify convergent findings, critical gaps, and implications for research and policy. The review uses 109 references and builds its evidence map from 194 original studies with 1,095,779 total participants/sample observations (topic-deduplicated ΣN). The dominant signal across this evidence map is a rapid, multi-country rise in nicotine pouch use that is concentrated among young males and tightly linked to concurrent use of cigarettes, vapes, and smokeless tobacco, with US adult past-30-day prevalence reaching 4.2% in 2024 and adolescent use doubling to 2.6% over the same period. Product chemistry is highly heterogeneous, and emerging clinical evidence indicates localized oral mucosal changes alongside reduced biomarker exposure when adult smokers fully switch. Together, these findings suggest a dual narrative in which nicotine pouches may support harm reduction for established adult smokers while simultaneously posing meaningful initiation risks for youth. Given the absence of long-term outcome data and the proliferation of novel analogues such as 6-methyl nicotine, the most pressing research priority is prospective cohort work quantifying chronic health effects and the net population impact of exclusive versus dual use.
.

Keywords: nicotine pouches; tobacco-free nicotine; oral nicotine products; youth nicotine use; nicotine pharmacokinetics; smoking cessation; flavored nicotine; tobacco harm reduction; nicotine advertising; dual tobacco use

Review Stats

Final search date and database lock: 2026-05-28 14:53:24 CEST
Plan: Pro (expanded craft tokens; source: PubMed)
Source: PubMed
Total Abstracts/Papers: 250
Downloaded Abstracts/Papers: 250
Included original and non-original Abstracts/Papers (all): 246
Included original Abstracts/Papers (Vote counting by direction of effect): 194
Reference Index (links used in paper): 109
Total participants/sample observations (topic deduplicated ΣN): 1,095,779

Get access to the full paper

Unlock the full evidence map

Full paper access includes the complete human-readable review, figures, reference index, PDF export, and machine-readable Evidence JSON download.
Evidence JSON can also be purchased separately if you only need the LLM-ready object for agent, AI, or RAG workflows.
Institutional or library access? Sign in with your institution email to open all available SAIMSARA papers under your institution access arrangement.
Need a SAIMSARA review on your own topic? ☸️Request.

Reference Index (108)

[1] Oral Nicotine Pouches: Rising Popularity and State of the Science. — https://doi.org/10.1177/00333549251313668
[2] What is the impact of nicotine pouches on oral health: a systematic review. — https://doi.org/10.1186/s12903-024-04598-8
[3] Nicotine Pouch and E-Cigarette Use and Co-Use Among US Youths in 2023 and 2024. — https://doi.org/10.1001/jamanetworkopen.2025.6739
[4] Nicotine Pouch Awareness and Use Among Youth, National Youth Tobacco Survey, 2021. — https://doi.org/10.1093/ntr/ntad080
[5] Nicotine pouch pharmacokinetics compared to smoked tobacco: A systematic review and meta-analysis. — https://doi.org/10.1016/j.dadr.2025.100389
[6] Tobacco-free Nicotine Pouch Use in Great Britain: A Representative Population Survey 2020-2021. — https://doi.org/10.1093/ntr/ntac099
[7] Characterization of Total and Unprotonated (Free) Nicotine Content of Nicotine Pouch Products. — https://doi.org/10.1093/ntr/ntab030
[8] Oral nicotine pouch use in Great Britain: a repeat cross-sectional study, 2020-25. — https://doi.org/10.1016/s2468-2667(25)00296-8

Unlock the full paper to view the complete Reference Index.